We also examined the effects of introduction WT-GSK-3β and KD-GSK-3β on the sensitivity of MCF-7 breast cancer cells to chemotherapeutic drugs, signal transduction inhibitors and a nutraceutical. The gene discussed is GSK3B; the disease is breast carcinoma.